Dr. Shulman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-355-6000
Education & Training
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2013 - 2016
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2012 - 2015
- Harvard Medical SchoolClass of 2013
Certifications & Licensure
- MA State Medical License 2016 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement.Matthew S Dietz, Alyaa Al-Ibraheemi, Jessica L Davis, C Matthew Hawkins, Brian T Craig
Journal of the National Comprehensive Cancer Network. 2024-12-27 - Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric Oncology.Hannah E Olsen, Pei-Chi Kao, Caleb Richmond, David S Shulman, Wendy B London
Cancer Medicine. 2024-12-01 - Targeted-Agent Continual Reassessment Method: A Novel Bayesian Enrichment Design for Phase I Trials of Molecularly Targeted Therapies.Clement Ma, David S Shulman, Hasan Al-Sayegh, Steven G DuBois, Wendy B London
JCO Precision Oncology. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: